Overexpression of the human MNB/DYRK1A gene induces formation of multinucleate cells through overduplication of the centrosome
© Funakoshi et al; licensee BioMed Central Ltd. 2003
Received: 17 April 2003
Accepted: 10 September 2003
Published: 10 September 2003
Previously we cloned the human MNB/DYRK1A gene from the "Down syndrome critical region" on chromosome 21. This gene encodes a dual specificity protein kinase that catalyzes its autophosphorylation on serine/threonine and tyrosine residues. But, the functions of the MNB/DYRK1A gene in cellular processes are unknown.
In this study, we examined HeLa cells transfected with cDNA encoding a green fluorescent protein (GFP)-MNB/DYRK1A fusion protein and found 2 patterns of expression: In one group of transfected cells, GFP-MNB/DYRK1A was localized as dots within the nucleus; and in the other group, it was overexpressed and had accumulated all over the nucleus. In the cells overexpressing GFP-MNB/DYRK1A, multinucleation was clearly observed; whereas in those with the nuclear dots, such aberrant nuclei were not found. Furthermore, in the latter cells, essential processes such as mitosis and cytokinesis occurred normally. Multinucleation was dependent on the kinase activity of MNB/DYRK1A, because it was not observed in cells overexpressing kinase activity-negative mutants, GFP-MNB/DYRK1A (K179R) and GFP-MNB/DYRK1A (Y310F/Y312F). Immunostaining of GFP-MNB/DYRK1A-overexpressing cells with specific antibodies against α- and γ-tubulin revealed that multiple copies of centrosomes and aberrant multipolar spindles were generated in these cells.
These results indicate that overexpression of MNB/DYRK1A induces multinucleation in HeLa cells through overduplication of the centrosome during interphase and production of aberrant spindles and missegregation of chromosomes during mitosis.
Down syndrome (trisomy 21) is the most frequent birth defect and is a major cause of mental retardation and congenital heart disease . Besides the characteristic set of facial and physical features of individuals afflicted with it, this syndrome is associated with defects of the immune and endocrine systems, an increased rate of leukemia, and early onset of Alzheimer disease . Although little is known about the mechanism by which trisomy 21 interferes with normal development, the increased dosage of the chromosomal elements clearly implies altered levels of gene expression as a causative factor.
In most cases, patients with Down syndrome show trisomy of chromosome 21. Studies of cases with partial trisomy of chromosome 21 have suggested that the region around locus D21S55 is particularly important in the etiology of the syndrome [2–4]. This subchromosomal region is called the "Down syndrome critical region." Earlier we performed exon trapping experiments using a series of cosmid clones isolated from this chromosomal region, and identified the genomic structure and cDNA sequence of the human MNB/DYRK1A gene in this region [5–7].
The human MNB/DYRK1A gene is a human homolog of Drosophila minibrain and rat DYRK genes. Mutant flies with a reduced expression of minibrain have a reduced number of neurons in distinct areas of the adult brain; and this gene is therefore required for a distinct neuroblast proliferation during postembryonic neurogenesis . A previous report on the rat DYRK protein showed that the DYRK gene encodes a dual specificity kinase that catalyzes its autophosphorylation on both serine/threonine and tyrosine residues [9–11]. The human MNB/DYRK1A gene has been suggested to be a strong candidate gene for learning defects associated with Down syndrome, because transgenic mice carrying a 180-kb YAC contig containing the human MNB/DYRK1A gene showed defects in learning and memory [12, 13]. But, the roles of the MNB/DYRK1A gene in cellular processes are far from established.
To clarify the physiological role of MNB/DYRK1A, in the present study we transfected HeLa cells with cDNA encoding a GFP-MNB/DYRK1A fusion protein. The subcellular localization of the transfected-MNB/DYRK1A depended on its expression level. In the case of a low level, the protein was concentrated at specific loci in the nucleus; but in the case of a high level, it was located all over the nucleus. This high-level expression of MNB/DYRK1A protein induced the overproduction of the centrosome and led to multinucleation in HeLa cells. These results indicate that MNB/DYRK1A may play a specific function in coordinating nuclear division with other cell-cycle progression events.
The enhanced level of MNB/DYRK1A protein induced the emergence of cells with multiple nuclei. This observation may be important, because aberrant overexpression of MNB/DYRK1A protein is thought to contribute to the characteristic features of Down syndrome. Although multinucleation can be produced via various mechanisms, defects in the mitotic machinery may play a major role in this nuclear abnormality. The mitotic machinery accurately separates and distributes chromosomes into each daughter cell. This accurate segregation is achieved by mitotic spindles composed of microtubules. So, we determined the effect of over-expressed GFP-MNB/DYRK1A on microtubule structures by immunostaining cells with an antibody specific for α-tubulin, a main constituent of microtubules (Fig. 6). When interphase cells were observed after the transfection with GFP, α-tubulin was detected in the cytoplasm, especially in the nuclear periphery (Fig. 6A, panel a). In a multinucleate cell, α-tubulin showed a localization similar to that in the GFP-transfected cell, but it was localized around a mass of nuclei rather than around each nucleus (Fig. 6A, panel c). At the M phase of the cell cycle, typical mitosis with a bipolar mitotic spindle was observed in the GFP-transfected cells (Fig. 6A, panel b), whereas aberrant mitotic spindles were noted in cells expressing a high level of GFP-MNB/DYRK1A (Fig. 6A, panel d). Further analysis of mitotic cells overexpressing GFP-MNB/DYRK1A revealed that tripolar spindles appeared in prometaphase cells (Fig. 6B, panel a) and that multiple mitotic spindle poles and abnormal chromosome condensation appeared in metaphase cells and late-anaphase cells (Fig. 6B, panels b and c).
The transfection experiments with cDNA encoding GFP-MNB/DYRK1A showed that the subcellular distribution pattern of GFP-MNB/DYRK1A protein depended on its intracellular expression level. When the expression level of transfected MNB/DYRK1A cDNA was low, MNB/DYRK1A protein was localized with a speckled pattern in the nucleus. A similar subnuclear localization of MNB/DYRK1A has been observed in both COS-7 cells and HEK293 cells transfected with the GFP fusion protein of MNB/DYRK1A [10, 11]. Furthermore, we found that MNB/DYKR1A without a GFP tag became localized with a speckled pattern in the nucleus. These findings indicate that the speckled distribution of GFP-MNB/DYRK1A in the nucleus is not an artifact. Thus, MNB/DYRK1A probably localizes to subnuclear domains in the nucleus; and its association with this distinct subnuclear structure may be critical for some specific function of MNB/DYRK1A, although we couldn't detect this subnuclear localization of endogenous MNB/DYRK1A by using our specific antibody against MNB/DYRK1A.
Similar speckled patterns of subnuclear localization have been shown for other proteins [14–18]. One of them is the transcription factor forkhead in rhabdomysarcoma (FKHR), and this protein is known to co-localize and interact with MNB/DYRK1A . We found that GFP-MNB/DYRK1A co-immunoprecipitated with FKHR by immunoprecipitation using anti-FKHR antibody (manuscript in preparation), indicating that FKHR binds to GFP-MNB/DYRK1A in HeLa cells. FKHR transcription factors mediate cell-cycle regulation of a variety of cell lines, dependent on the cell-cycle inhibitor p27 kip 1. They also play a role in the control of gene expression by insulin, as well as in the regulation of apoptosis mediated by survival factors [20–22]. These signals trigger the phosphorylation of FKHR at 3 residues (Thr24, Ser253 and Ser319) catalyzed by protein kinase B through a phosphoinositide-3-kinase-dependent pathway. MNB/DYRK1A phosphorylates Ser329 residue on FKHR in vivo , but upstream kinases that can phosphorylate and activate MNB/DYRK1A are still unknown. The phosphorylation of these residues including Ser329 on FKHR has been reported to reduce the proportion of FKHR present within the nuclei and to decrease the ability of FKHR to stimulate gene transactivation [19–22]. MNB/DYRK1A in a discrete subnuclear structure may, therefore, play a role in the control of cell-cycle progression or apoptosis by regulating the nuclear level of FKHR.
HeLa cells with a speckled pattern in their nucleus progressed into M phase and produced 2 daughter cells, and both the condensation and subsequent segregation of chromosomes occurred in these cells as properly as in non-transfected control cells. On the other hand, in HeLa cells expressing a high level of MNB/DYRK1A, multinucleation was observed. Immunostaining with antibody specifically recognizing γ-tubulin revealed that the multinucleation had resulted from overduplication of the centrosome. Balczon and co-workers  reported that CHO cells arrested at the G1/S boundary of the cell cycle by treatment with hydroxyurea underwent multiple rounds of centrosome replication in the complete absence of DNA synthesis and cell division. Thus, one possible explanation for the overduplication of the centrosome, which was seen in this study, is that the overexpression of MNB/DYRK1A influences cell-cycle progression, possibly by affecting the nuclear level of FKHR. For cell division to occur properly, the centrosome must be duplicated once during each cell cycle; and thus in normal cells, the centrosome duplication cycle is tightly regulated. Failure of the normal cycle of this duplication would result either in cell-cycle arrest before the onset of mitosis or in the formation of an aberrant monopolar or multipolar spindle [24–27]. It is possible that the overexpression of MNB/DYRK1A induces the overduplication of the centrosome prior to the next mitosis, subsequently producing multiple spindle poles leading to the multinucleation.
MNB/DYRK1A is a dual specificity protein kinase whose activity depends on the phosphorylation of tyrosines in its activation loop [28, 29]. Outside this catalytic domain, the sequence comprises a bipartite nuclear translocation signal (amino acids 105–139). A previous report showed that the nuclear translocation of MNB/DYRK1A is mediated by this signal sequence but that its characteristic subnuclear localization depends on additional N-terminal elements . Thus, the protein kinase activity of MNB/DYRK1A is not required for its subnuclear localization. We have also obtained data leading to the same conclusion: when cDNA encoding kinase activity-negative mutants, GFP-MNB/DYRK1A (K179R) and GFP-MNB/DYRK1A (Y310F/Y312F), were used to transfect HeLa cells, speckled signals were detected in the nucleus (data not shown). On the other hand, cells with multinuclei were not observed if the kinase activity-negative mutants were overexpressed. It thus appears that the kinase activity of MNB/DYRK1A is essential for the formation of multinucleation, but not for its speckled subnuclear formation with FKHR.
Centrosome overduplication and multi-polar mitotic spindles were also observed in some tumor cells after γ-irradiation [30, 31]. Since mitotic cell death was predominantly observed in these irradiated cells, cells expressing a higher level of MNB/DYRK1A than that in normal cells may die in a similar fashion. A possibility that mitotic cell death or apoptosis may occur in MNB/DYRK1A-overexpressing cells is worth studying, because brain development is markedly affected in Down syndrome patients and the number of neurons is reduced in their brain [32, 33].
In this study, we found that overexpression of MNB/DYRK1A induced overduplication of the centrosome during interphase, resulting in aberrant spindles and missegregation of chromosomes during mitosis and subsequent multinucleation. A major goal of Down syndrome research is to correlate dosage imbalance of specific genes from human chromosome 21 with various clinical aspects of the syndrome. Our experimental system using overexpression of MNB/DYRK1A is a very useful model for studying the effect of gene dosage in Down syndrome in vitro. Further studies on the molecular mechanism underlying centrosome dysregulation by overexpression of MNB/DYRK1A should provide more important insights into the role of this protein kinase in Down syndrome.
The following materials were purchased from the sources indicated: Mouse antibodies against α-tubulin, γ-tubulin, and FLAG epitope from Sigma Chemical Co. (St. Louis, MO); Cy3-conjugated anti-mouse IgG antibody and Cy3-conjugated anti-rabbit IgG antibody from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA); fluorescein isothiocyanate-conjugated anti-mouse IgG antibody from Leinco Technologies, Inc. (St. Louis, MO); Hoechst33342 and TOTO-3 from Molecular Probes Inc. (Eugene, OR); LipofectAMINE reagent and Opti-MEM I from Invitrogen Co. (Carlsbad, CA). All other chemicals were commercial products of reagent grade.
HeLa cells were maintained at 37°C in a 5% CO2 atmosphere in Dulbecco's modified Eagle's (DME) medium supplemented with 10% fetal calf serum and 10 μg/ml kanamycin.
A full-length MNB/DYRK1A cDNA was isolated from a human fetal brain cDNA library as described previously . For the construction of the GFP-MNB/DYRK1A expression vector, a carboxy terminal FLAG sequence was added by PCR to full-length MNB/DYRK1A cDNA by using specific primers (MNB2069F: 5'-caatcaggcctaccagaatcgccca-3', and MNB cFLAGR: 5'-ccgctcgagtctagatcacttgtcatcgtcgtccttgtagtccgagctagctacaggactct-3'), and it was subcloned into the pEGFPC2 expression vector (Clontech, San Diego, CA) at the HindIII and XhoI sites. For the construction of expression vectors for kinase activity-negative mutants (GFP-MNB/DYRK1A-K179R and GFP-MNB/DYRK1A-Y310F/Y312F), site-directed mutagenesis was performed by use of the following primers: MNB590 (KR) F, 5'-atgggttgccattagaataataaag-3', and MNB590 (KR) R, 5'-ctttattattctaatggcaacccat-3', and MNB988 (2YF) F, 5'-agaggatattccagtttattcagag-3', and MNB988 (2YF) R, 5'-ctctgaataaactggaatatcctct-3'. The PCR products were then subcloned into the GFP-MNB/DYRK1A expression vector to generate the GFP-MNB/DYRK1A (K179R) and GFP-MNB/DYRK1A (Y310F/Y312F) expression vectors. For the construction of a GFP-tagged NLS expression vector, the following oligonucleotides were synthesized: MNB381S, 5'-gaagatctcgaaaaagaagcgaagacaccaacagggccagggagacgattctagtcataagaaggaacggaagagctcaagcttcgaattccg-3'; and MNB381AS, cggaattcgaagcttgagctcttccgttccttcttatgactagaatcgtctccctggccctgttggtgtcttcgcttctttttcgagatcttc-3'. After having been annealed and digested with BglII and EcoRI, the resulting BglII and EcoRI-codigested DNA fragment was subcloned into the BglII and EcoRI sites of the pEGFPC2 expression vector to generate the GFP-NLS expression vector. For the construction of a FLAG epitope-tagged expression vector for wild-type MNB/DYRK1A, GFP-MNB/DYRK1A was digested with HindIII and ApaI sites of the pcDNA3.1 vector (Invitrogen, Carlsbad, CA) to generate the pcDNA-MNB/DYRK1A. All constructs obtained were confirmed by nucleotide sequencing with an ABI377 DNA Sequencer (Applied Biosystems, Foster, CA).
Immunostaining of cells for confocal laser scanning microscopic observation
Transient transfection with constructs encoding GFP-MNB/DYRK1A and FLAG epitope-tagged MNB/DYRK1A were carried out by using LipofectAMINE reagent as recommended by the manufacturer. Briefly, HeLa cells were seeded onto cover slips in 35-mm dishes at least more than 24 hours before transfection. The plasmid DNA was mixed with LipofectAMINE reagent in serum-free Opti-MEM, incubated at room temperature for 30 minutes, and then added to the seeded cells. The total amount of transfected plasmid DNA was 1.0 μg per dish. At 3 hours after the addition of the plasmid DNA, the transfection mixture was replaced with DME medium supplemented with 10% fetal calf serum. The cells were then incubated in a CO2 incubator for 24–48 hours, washed twice with ice-cold phosphate-buffered saline (PBS), and then fixed with methanol for 5 minutes at -20°C. The fixed cells were washed 3 times with PBS and were subsequently incubated for 2 hours with anti-α-tubulin antibody (1:200), anti-γ-tubulin antibody (1:200), anti-FLAG antibody (1:200), or anti-MNB antibody (1:50) . They were then incubated for 1 hour with 1 μM TOTO-3 and goat Cy3-conjugated anti-mouse IgG antibody (1:100), donkey Cy3-conjugated anti-rabbit IgG antibody (1:100), or goat fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG antibody (1:100) at room temperature. The stained cells were observed with a confocal laser scanning microscope (MRC1024, Bio-Rad). A total of 200 cells were examined for centrosome number and for percentage of multinucleate cells in each of 3 independent experiments.
Microscopic observation of MNB/DYRK1A in living cells during the cell cycle
The procedure for preparation of fluorescently-stained living cells for microscopic observation was described previously [34, 35]. Briefly, HeLa cells were plated on a 35-mm glass-bottom culture dish (MatTek Corp., Ashland, MA) and cultured for 1 day in a CO2 incubator in 2 ml of DME medium supplemented with 10% fetal calf serum. The cells were then transiently transfected with the plasmid DNA encoding the GFP-MNB/DYRK1A fusion gene by using LipofectAMINE reagent. At 24 hours after the transfection, the cells were stained with 100 ng/ml of Hoechst33342 for 5–30 minutes and then washed 3 times with DME medium supplemented with 10% calf serum. The Hoechst33342-stained cells were cultured in a phenol red-free DME medium supplemented with 10% fetal bovine serum in a CO2 incubator for at least 30 minutes and used for microscopic observation. This medium also contained 80 μg/ml of kanamycin sulfate and Hepes buffer (pH 7.4) at a final 20 mM concentration.
This work was supported in part by grants-in-aid for scientific research to F.I. from the Ministry of Education, Science, Sports, and Culture of Japan and by a fund for the Research for the Future Program from the Japan Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science and Technology (MEXT).
- Epstein CJ: The Consequences of Chromosome Imbalance: Principles, Mechanisms, and Models. Cambridge Univ. Press New York. 1986View ArticleGoogle Scholar
- Rahmani Z, Blouin J, Creau-Goldberg N, Watkins PC, Mattei J, Poissonnier M, Prieur M, Chettouh Z, Nicole A, Aurias A, Sinet P, Delabar J: Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome. Proc Natl Acad Sci USA. 1989, 86: 5958-5962.PubMed CentralView ArticlePubMedGoogle Scholar
- Korenberg JR, Chen XN, Schipper R, Sun Z, Gonsky R, Gerwehr S, Carpenter N, Daumer C, Dignan P, Disteche C, Graham JM, Hugdins L, McGillivray B, Miyazaki K, Ogasawara N, Park JP, Pagon R, Pueschel S, Sack G, Say B, Schuffenhauer S, Soukup S, Yamanaka T: Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci USA. 1994, 91: 4997-5001.PubMed CentralView ArticlePubMedGoogle Scholar
- Delabar JM, Theophile D, Rahmani Z, Chettouh Z, Blouin JL, Prieur M, Noel B, Sinet PM: Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur J Hum Genet. 1993, 1: 114-124.PubMedGoogle Scholar
- Shindoh N, Kudoh J, Maeda H, Yamaki A, Minoshima S, Shimizu Y, Shimizu N: Cloning of a human homolog of the Drosophila minibrain/rat Dyrk gene from "the Down syndrome critical region" of chromosome 21. Biochem Biophys Res Commun. 1996, 225: 92-99. 10.1006/bbrc.1996.1135.View ArticlePubMedGoogle Scholar
- Wang J, Kudoh J, Shintani A, Minoshima S, Shimizu N: Identification of two novel 5' noncoding exons in human MNB/DYRK gene and alternatively spliced transcripts. Biochem Biophys Res Commun. 1998, 250: 704-710. 10.1006/bbrc.1998.9392.View ArticlePubMedGoogle Scholar
- Okui M, Ide T, Morita K, Funakoshi E, Ito F, Ogita K, Yoneda Y, Kudoh J, Shimizu N: High-level expression of the Mnb/Dyrk1A gene in brain and heart during rat early development. Genomics. 1999, 62: 165-171. 10.1006/geno.1999.5998.View ArticlePubMedGoogle Scholar
- Tejedor F, Zhu XR, Kaltenbach E, Ackermann A, Baumann A, Canal I, Heisenberg M, Fishbach KF, Pongs O: minibrain: A new protein kinase family involved in postembryonic neurogenesis in Drosophila. Neuron. 1995, 14: 287-301.View ArticlePubMedGoogle Scholar
- Kentrup H., Becker W, Heukelbach J, Wilmes A, Schurmann A, Huppertz C, Kainulainen H, Joost HG: Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. J Biol Chem. 1996, 271: 3488-3495. 10.1074/jbc.271.7.3488.View ArticlePubMedGoogle Scholar
- Leder S, Weber Y, Altafaj X, Estivill X, Joost HG, Becker W: Cloning and characterization of DYRK1B, a novel member of the DYRK family of protein kinases. Biochem Biophys Res Commun. 1999, 254: 474-479. 10.1006/bbrc.1998.9967.View ArticlePubMedGoogle Scholar
- Becker W, Weber Y, Wetzel K, Eirmbter K, Tejedor FJ, Joost HG: Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. J Biol Chem. 1998, 273: 25893-25902. 10.1074/jbc.273.40.25893.View ArticlePubMedGoogle Scholar
- Smith DJ, Rubin EM: Functional screening and complex traits: human 21q22.2 sequences affecting learning in mice. Hum Mol Genet. 1997, 6: 1729-1733. 10.1093/hmg/6.10.1729.View ArticlePubMedGoogle Scholar
- Smith DJ, Stevens ME, Sudanagunta SP, Bronson RT, Makhinson M, Watanabe AM, O'Dell TJ, Fung J, Weier HU, Cheng JF, Rubin EM: Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nature Genet. 1997, 16: 28-36.View ArticlePubMedGoogle Scholar
- Everett RD, Lomonte P, Sternsdorf T, van Driel R, Orr A: Cell cycle regulation of PML modification and ND10 composition. J Cell Sci. 1999, 112: 4581-4588.PubMedGoogle Scholar
- Sternsdorf T, Jensen K, Zuchner D, Will H: Cellular localization, expression, and structure of the nuclear dot protein 52. J Cell Biol. 1997, 138: 435-448. 10.1083/jcb.138.2.435.PubMed CentralView ArticlePubMedGoogle Scholar
- Maser RS, Monsen KJ, Nelms BE, Petrini JH: hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol Cell Biol. 1997, 17: 6087-6096.PubMed CentralView ArticlePubMedGoogle Scholar
- Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM: Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell. 1997, 90: 425-435.View ArticlePubMedGoogle Scholar
- Fu XD, Maniatis T: Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus. Nature. 1990, 343: 437-441. 10.1038/343437a0.View ArticlePubMedGoogle Scholar
- Woods YL, Rena G, Morrice N, Barthel A, Becker W, Guo S, Unterman TG, Cohen P: The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Biochem J. 2001, 355: 597-607.PubMed CentralView ArticlePubMedGoogle Scholar
- Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999, 96: 857-868.View ArticlePubMedGoogle Scholar
- Guo S, Rena G, Cichy S, He X, Cohen P, Unterman T: Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J Biol Chem. 1999, 274: 17184-17192. 10.1074/jbc.274.24.17184.View ArticlePubMedGoogle Scholar
- Tang ED, Nunez G, Barr FG, Guan KL: Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem. 1999, 274: 16741-16746. 10.1074/jbc.274.24.16741.View ArticlePubMedGoogle Scholar
- Balczon R, Bao L, Zimmer WE, Brown K, Zinkowski RP, Brinkley BR: Dissociation of centrosome replication events from cycles of DNA synthesis and mitotic division in hydroxyurea-arrested chinese hamster ovary cells. J Cell Biol. 1995, 130: 105-115.View ArticlePubMedGoogle Scholar
- Rose MD, Biggins S, Satterwhite LL: Unravelling the tangled web at the microtubule-organizing center. Curr Opin Cell Biol. 1993, 5: 105-115.View ArticlePubMedGoogle Scholar
- Kellogg DR, Moritz M, Alberts BM: The centrosome and cellular organization. Annu Rev Biochem. 1994, 63: 639-674. 10.1146/annurev.bi.63.070194.003231.View ArticlePubMedGoogle Scholar
- Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, Doxsey SJ: Centrosome defects and genetic instability in malignant tumors. Cancer Res. 1998, 58: 3974-3985.PubMedGoogle Scholar
- Lingle WL, Salisbury JL: Altered centrosome structure is associated with abnormal mitoses in human breast tumors. Am J Pathol. 1999, 155: 1941-1951.PubMed CentralView ArticlePubMedGoogle Scholar
- Wiechmann S, Czajkowska H, de Graaf K, Grotzinger J, Joost HG, Becker W: Unusual function of the activation loop in the protein kinase DYRK1A. Biochem Biophys Res Commun. 2003, 302: 403-408. 10.1016/S0006-291X(03)00148-7.View ArticlePubMedGoogle Scholar
- Himpel S, Panzer P, Eirmbter K, Czajkowska H, Sayed M, Packman LC, Blundell T, Kentrup H, Grotzinger J, Joost HG, Becker W: Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A. Biochem J. 2001, 359: 497-505. 10.1042/0264-6021:3590497.PubMed CentralView ArticlePubMedGoogle Scholar
- Sato N, Mizumoto K, Nakamura M, Tanaka M: Radiation-induced centrosome overduplication and multiple mitotic spindles in human tumor cells. Exp Cell Res. 2000, 255: 321-326. 10.1006/excr.1999.4797.View ArticlePubMedGoogle Scholar
- Sato N, Mizumoto K, Nakamura M, Ueno H, Minamishima YA, Farber JL, Tanaka M: A possible role for centrosome overduplication in radiation-induced cell death. Oncogene. 2000, 19: 5281-5290. 10.1038/sj.onc.1203902.View ArticlePubMedGoogle Scholar
- Ross MH, Galaburda AM, Kemper TL: Down's syndrome: is there a decreased population of neurons?. Neurology. 1984, 34: 909-916.View ArticlePubMedGoogle Scholar
- Ieshima A, Kisa T, Yoshino K, Takashima S, Takeshita K: A morphometric CT study of Down's syndrome showing small posterior fossa and calcification of basal ganglia. Neuroradiology. 1984, 26: 493-498.View ArticlePubMedGoogle Scholar
- Haraguchi T, Ding DQ, Yamamoto A, Kaneda T, Koujin T, Hiraoka Y: Multiple color fluorescence imaging of chromosome and microtubules in living cells. Cell Struct Funct. 1999, 24: 291-298. 10.1247/csf.24.291.View ArticlePubMedGoogle Scholar
- Haraguchi T, Kaneda T, Hiraoka Y: Dynamics of chromosomes and microtubules visualized by multiple-wavelength fluorescence imaging in living mammalian cells: effects of mitotic inhibitors on cell cycle progression. Genes Cells. 1997, 2: 369-380. 10.1046/j.1365-2443.1997.1280326.x.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.